Price Registration for Drug Acquisition (Ceftixona 500Mg Powder for Injectable Solution... Tender

Procurement Summary

Country : Brazil

Summary : Price Registration for Drug Acquisition (Ceftixona 500Mg Powder for Injectable Solution + Lidocaine; 0.2 Mg/Ml Injectable Solution; Dexamethasone (Disodium Phosphate) 4 Mg/Ml Solution i ...

Deadline : 29 Apr 2025

Other Information

Notice Type : Tender

TOT Ref.No.: 117621961

Document Ref. No. : 90045/2025

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Object: Electronic Auction - Price Registration for Medicines Acquisition (CEFTIxONA 500mg Powder for Injectable Solution + Lidocaine; DESLANOSIRE 0.2 mg/ml Injectable Solution; Dexamethasone (Disodic Phosphate) 4 mg/ml Injectable solution; Phenobarbital 100 mg/ml Injectable solution;10% injectable solution ampoule; Hydralazine 20mg/ml Injectable solution; morphine, sulfate 10 mg/ml injectable solution; morphine, 0.2 mg/ml sulfate intratecal injectable solution IV/IM; NO

UASG Code: 985703

Notice from: 11/04/2025 from 08:00 to 17:59 hs

Proposal Delivery: FromFrom 04/11/2025 to 08: 00hs

ceftriaxone, physical aspect of whitish crystalline yellowish orange, chemical formula C18H16n8S3O7NA2.7/2h20 (hydrated sodium salt), molecular weight 661.59 g/mol, minimum purity degree 99.8%, standard characteristic of analytical reference, numberChemical Reference Cas 104376-79-6

Quantity: 23400

DeslanoSid, dosage 0.2 mg/ml, Presentation Injectable Solution

Quantity: 650

Dexamethasone, Concentration 2 mg/ml, injectable solution, veterinary use

Quantity: 31200

phenobarbital, physical powder crystalline powder, formulaChemistry C12H12N2O3, molecular mass 232.08 g/mol, minimum purity degree of 99%, chemical reference number 50-06-6

quantity: 500

calcium glycoat, composition associated with magnesium hypophosphite, other components of magnesium, dextrose and boric acid, concentration 20% + 3.2%+ 1.9% + 5% + 4%, physical form injectable solution, use veterinary use

Quantity: 650

hydralazine, dosage 20 mg/ml, indication injectable solution

quantity: 650

morphine, sulfate presentation, concentration 10mg/ml, pharmaceutical form injectable solution

quantity, 1560

morphine, sulfate presentation, 0.2mg/ml concentration, pharmaceutical form injectable solution

Quantity: 800

naloxone hydrochloride, dosage 0.4 mg/ml, a ...

Documents

 Tender Notice